Adoption of Serogroup B Meningococcal Vaccine Recommendations

BACKGROUND: In 2015, ACIP recommended 16–23 year olds may be vaccinated with serogroup B meningococcal (MenB) vaccine based on individual clinical decision-making (Category B). OBJECTIVE: To assess among US pediatricians (Peds) and family physicians (FPs): 1) practices regarding MenB vaccine deliver...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Pediatrics
Glavni autori: Kempe, Allison, Allison, Mandy A., MacNeil, Jessica R., O’Leary, Sean T., Crane, Lori A., Beaty, Brenda L., Hurley, Laura P., Brtnikova, Michaela, Lindley, Megan C., Albert, Alison P.
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6200322/
https://ncbi.nlm.nih.gov/pubmed/30126935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2018-0344
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items